Evidence map›Paper›PMID 39353443›Full record

ArticleThe American journal of tropical medicine and hygiene2024

Nonparametric Testing of Body Mass Index as a Predictor of Severe Noma: Assessing Potential Association.

Heron G Gebretsadik

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Heron G GebretsadikSchool of Global Health and Bioethics, Euclid University, Banjul, The Gambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noma, a devastating facial disease, primarily affects impoverished populations in low- and middle-income countries, often leading to severe disfigurement or fatality if untreated. Studies suggest malnutrition is a significant risk factor for noma, yet the association between body mass index (BMI) in kilograms per square meter and tissue damage severity remains underexplored. This study aimed to investigate the relationship between BMI and tissue damage severity among noma cases in Ethiopia. A retrospective analysis of medical records from Facing Africa's database covering noma cases treated between 2007 and 2019 was conducted. A standardized data collection template recorded demographic and clinical data, including patient demographics, BMI, and tissue damage severity levels. JASP statistical software was used for analysis. Analysis of 228 noma cases revealed a mean BMI of 17.8 kg/m2, ranging from 11.5 to 28.3 kg/m2. Females exhibited a higher mean BMI (18.3 kg/m2) than males (16.9 kg/m2). Differences in BMI distributions between major (67) and minor (30) tissue damage categories were observed, with "minor" cases having a slightly higher mean BMI. The study found a statistically significant association between BMI and tissue damage severity (P = 0.03), indicating that tissue damage due to noma worsened as BMI decreased. Nonparametric tests confirmed this association's significance. This study highlights low BMI as a predictor of severe noma. Public health interventions should focus on malnutrition to reduce noma severity and psychosocial and functional morbidity and improve outcomes. However, additional factors influencing the progression of noma and the severity of associated tissue damage require further investigation.

Indexed as

Body Mass IndexNomaAdolescentAdultAgedChildEthiopiaFemaleHumansMaleMalnutritionMiddle AgedRetrospective StudiesRisk FactorsSeverity of Illness IndexYoung Adult

Identifiers

PMID39353443
PMCPMC11619514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.